Clinical Trial Update: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents [Phase 4]

View source ↗

Summary

This Phase 4 open-label study evaluates the safety and tolerability of iloperidone in adolescents with schizophrenia or bipolar I disorder and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Iloperidone (iloperidone)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Schizophrenia, Bipolar I Disorder | Phase 4 | Status: RECRUITING